# Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema

> **NCT06787885** · NA · RECRUITING · sponsor: **Fayoum University** · enrollment: 90 (estimated)

## Conditions studied

- Empyema, Pleural

## Interventions

- **DRUG:** Levofloxacin + clindamycin
- **DRUG:** Levofloxacin + cefipime
- **DRUG:** Moxifloxacin + meronam

## Key facts

- **NCT ID:** NCT06787885
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06787885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06787885, "Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06787885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*